Company: AEMD
Filing Date: 2025-02-12
Form Type: 10-Q
Source: 0001683168-25-000960
Chunk: 40

Company: AETHLON MEDICAL INC
Filing Date: 2025-02-12
Form: 10-Q
Item: Item 1
Chunk 40
---
 resources; our inability to manage our growth could delay or derail implementation of our business objectives.

    ·
    
    Our success is dependent in part on our executive
officers.

    ·
    
    We have not received, and may never receive,
approval from the FDA to market a medical device in the United States. Even though we have received breakthrough device designation for
the Hemopurifier for two independent indications, this designation may not expedite the development or review of the Hemopurifier and
does not provide assurance ultimately of PMA submission or approval by the FDA.

    ·
    Delays in successfully commencing or completing our planned clinical trials could jeopardize our ability to obtain regulatory approval and sustain our operations.

There have been no material changes to the risk
factors previously disclosed under the heading “Risk Factors” in our Annual Report. The risks described in our Annual Report
are not the only risks facing our company. Additional risks and uncertainties not currently known to us or that we currently deem to be
immaterial also may materially adversely affect our business, financial condition or future results.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES
AND USE OF PROCEEDS.

We did not issue or sell any unregistered securities during the three
months ended December 31, 2024.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

Rule 10b5-1 Trading Plans 

During the three months ended December 31, 2024,
none of our directors or officers entered into, modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule
10b5-1 trading arrangement,” that were intended to satisfy the affirmative defense conditions of Rule 10b5-1, in each case as defined
in Item 408 of Regulation S-K.

 30 

ITEM 6. EXHIBITS.

(a) Exhibits. The following documents are filed
as part of this report:

    Incorporated
    by Reference
  
    Exhibit
Number
     
    Exhibit Description
     
    Form
     
    SEC File No.
     
    Exhibit
Number
     
    Date
     
    Filed
Herewith

    3.1
     
    Articles of Incorporation, as amended.
     
    8-K